Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Poor performance of hepatitis C antibody tests in hospital patients in Uganda.

Seremba E, Ocama P, Opio CK, Kagimu M, Thomas DL, Yuan HJ, Attar N, Lee WM.

J Med Virol. 2010 Aug;82(8):1371-8. doi: 10.1002/jmv.21817.

PMID:
20572078
[PubMed - indexed for MEDLINE]
2.

Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda.

Seremba E, Ocama P, Opio CK, Kagimu M, Yuan HJ, Attar N, Thomas DL, Lee WM.

J Med Virol. 2010 Aug;82(8):1334-40. doi: 10.1002/jmv.21813.

PMID:
20572076
[PubMed - indexed for MEDLINE]
3.

Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.

de Medina M, Hill M, Sullivan HO, Leclerq B, Pennell JP, Jeffers L, Reddy KR, Schiff ER, Perez GO.

J Lab Clin Med. 1998 Jul;132(1):73-5.

PMID:
9665375
[PubMed - indexed for MEDLINE]
4.

Hepatitis C virus infection in hemodialysis patients: comparison of two new hepatitis C antibody assays with a second-generation assay.

al Meshari K, Alfurayh O, Al Ahdal M, Qunibi W, Kessie G, De Vol E.

J Am Soc Nephrol. 1995 Nov;6(5):1439-44.

PMID:
8589320
[PubMed - indexed for MEDLINE]
Free Article
5.

Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.

Macedo de Oliveira A, White KL, Beecham BD, Leschinsky DP, Foley BP, Dockter J, Giachetti C, Safranek TJ.

J Clin Virol. 2006 Jan;35(1):21-5.

PMID:
15921955
[PubMed - indexed for MEDLINE]
6.

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.

Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M.

Hepatology. 1997 Oct;26(4):1006-11.

PMID:
9328327
[PubMed - indexed for MEDLINE]
7.

Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.

Hyland C, Seed CR, Kiely P, Parker S, Cowley N, Bolton W.

Vox Sang. 2003 Jul;85(1):1-8.

PMID:
12823724
[PubMed - indexed for MEDLINE]
8.

Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.

Caspari G, Gerlich WH, Beyer J, Schmitt H.

Infusionsther Transfusionsmed. 1995 Aug;22(4):208-19.

PMID:
7496119
[PubMed - indexed for MEDLINE]
9.
10.
11.

Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?

Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS.

J Viral Hepat. 2004 Nov;11(6):563-70.

PMID:
15500558
[PubMed - indexed for MEDLINE]
12.

Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.

Krarup HB, Jacobsen SE, Varming K, Drewes AM, Madsen PH.

Dan Med Bull. 1998 Feb;45(1):89-91.

PMID:
9504268
[PubMed - indexed for MEDLINE]
13.

Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.

Gonçales NS, Costa FF, Vassallo J, Gonçales FL Jr.

Rev Inst Med Trop Sao Paulo. 2000 Sep-Oct;42(5):263-7.

PMID:
11058936
[PubMed - indexed for MEDLINE]
Free Article
14.

Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.

Pawlotsky JM, Fleury A, Choukroun V, Deforges L, Roudot-Thoraval F, Aumont P, Duval J, Dhumeaux D.

J Clin Microbiol. 1994 May;32(5):1357-9.

PMID:
7519631
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.

Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, Calderaro A, Chezzi C, Dettori G.

J Med Virol. 2004 Jul;73(3):397-403.

PMID:
15170635
[PubMed - indexed for MEDLINE]
16.

Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.

Widell A, Månsson AS, Sundström G, Hansson BG, Nordenfelt E.

J Med Virol. 1991 Dec;35(4):253-8.

PMID:
1724983
[PubMed - indexed for MEDLINE]
17.

Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.

Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB.

Clin Chem. 2003 Mar;49(3):479-86.

PMID:
12600961
[PubMed - indexed for MEDLINE]
Free Article
19.

Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.

Dow BC, Munro H, Buchanan I, Ferguson K, Davidson F, Lycett C, Jarvis M, Cleland A, Petrik J, Lumley S, MacLean A.

Vox Sang. 2004 Jan;86(1):15-20.

PMID:
14984555
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk